GlassScriptPhysician profile
Hyun-Joo Park
NPI 1497003750
$6,726.79
in general payments reported to CMS, 2019-2025
37 companies · $2,082 in 2025
The $2,082 reported for 2025 was more than what 93% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $149 · 2022: $514 · 2023: $1,933 · 2024: $2,049 · 2025: $2,082.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,030 · Education: $34.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,029.99 |
| Education | $34.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,195.74 | 2021-2025 | Jardiance, Ofev, Spiriva Respimat |
| Lilly USA, LLC | $533.16 | 2022-2025 | Mounjaro, Jardiance, Zepbound |
| Abbvie INC. | $509.15 | 2022-2025 | |
| Amgen INC. | $463.26 | 2023-2025 | Evenity, Repatha, Prolia |
| Glaxosmithkline, LLC. | $453.68 | 2022-2025 | Arexvy, Trelegy Ellipta, Shingrix |
| Merck Sharp & Dohme LLC | $421.80 | 2023-2025 | Winrevair, Dificid, Belsomra |
| Astrazeneca Pharmaceuticals LP | $369.61 | 2023-2025 | Tezspire, Farxiga, Airsupra |
| Novo Nordisk INC | $339.85 | 2022-2025 | Ozempic, Rybelsus, Wegovy |
| Abiomed | $323.41 | 2023-2024 | Impella |
| Regeneron Healthcare Solutions, INC. | $307.91 | 2021-2025 | Dupixent |
| Medtronic, INC. | $258.22 | 2023-2024 | Percept PC Brainsense |
| Verona Pharma, INC. | $160.08 | 2025 | Ohtuvayre |
| Insmed, INC. | $144.51 | 2023-2025 | Arikayce |
| Phathom Pharmaceuticals, INC. | $129.97 | 2025 | Voquezna |
| Biohaven Pharmaceutical Holding Company LTD. | $119.99 | 2022 |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $118.62 | 2022-2023 | Hillrom - Life 2000 Ventilation System |
| Grifols USA, LLC | $113.61 | 2022-2025 | Prolastin-C Liquid |
| Genzyme Corporation | $111.77 | 2021-2025 | |
| Pfizer INC. | $99.28 | 2023-2025 | |
| United Therapeutics Corporation | $66.15 | 2023-2025 | Tyvaso, Tyvaso |
| Electromed, INC. | $63.51 | 2021-2024 | Smartvest |
| Vifor Pharma, INC. | $51.43 | 2024 | Zemaira, Veltassa |
| Aimmune Therapeutics, INC. | $48.09 | 2024-2025 | Vowst, Zenpep |
| E.R. Squibb & Sons, L.L.C. | $38.32 | 2022-2023 | Eliquis |
| Ani Pharmaceuticals, INC. | $31.30 | 2025 | Purified Cortrophin Gel |
| Edwards Lifesciences Corporation | $30.66 | 2023-2024 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Teleflex LLC | $30.62 | 2025 | Urolift |
| Idorsia Pharmaceuticals US INC | $27.27 | 2023 | Quviviq |
| Takeda Pharmaceuticals U.S.A., INC. | $22.79 | 2024 | Glassia |
| Nabriva Therapeutics, Plc | $22.25 | 2022 | |
| Actelion Pharmaceuticals US, INC. | $22.17 | 2025 | Opsumit, Uptravi |
| Hologic Sales and Service, LLC | $20.64 | 2022 | |
| Axsome Therapeutics, INC. | $19.83 | 2023 | Sunosi |
| Sumitomo Pharma America, INC. | $15.18 | 2024 | Gemtesa |
| Exact Sciences Corporation | $15.18 | 2025 | Cologuard Collection Kit |
| Philips North America LLC | $14.30 | 2025 | Vest Therapy Und |
| Seqirus USA INC | $13.48 | 2023 | Fluad Quadrivalent, Flucelvax Quadrivalent |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hyun-Joo Park listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.